These translations help make sense of initials commonly used by clinical researchers around the world.
AAAS American Association for the Advancement of Science
AABB American Association of Blood Banks
AADA Abbreviated Antibiotic Drug Application (FDA) (used primarily for generics)
AAMC Association of American Medical Colleges
AAPS American Association of Pharmaceutical Scientists
ABPI Association of the British Pharmaceutical Industry
ACCP American College of Clinical Pharmacology
ACDM Association for Clinical Data Management (UK)
ACE angiotensin-converting enzyme
ACIL A national trade association representing independent, commercial scientific, and engineering firms
ACPU Association of Clinical Pharmacology Units
ACRA Associate Commissioner for Regulatory Affairs (FDA)
ACRP Association of Clinical Research Professionals (formerly Associates in Clinical Pharmacology, ACP)
ACRPI Changed its name to ICR–Institute of Clinical Research (UK)
ACTApplied Clinical Trials magazine
ACTG AIDS Clinical Trials Group (NIAID)
ACTU AIDS Clinical Trials Unit (NIH)
ADaM Analysis Dataset Model (CDISC)
ADAMHA Alcohol, Drug Abuse, and Mental Health Administration (no longer exists)
ADE Adverse Drug Event; Adverse Drug Effect
ADME absorption, distribution, metabolism, and excretion (used to describe pharmacokinetic processes)
ADR adverse drug reaction
AE adverse event
AEGIS ADROIT Electronically Generated Information Service, a subscription service that provides subscribing organizations with access to adverse drug reaction data from the Medicines Control Agency's ADROIT (Adverse Drug Reaction On-line Information Tracking) database
AERS Adverse Event Reporting System (FDA)
AFCR See AFMR.
AFMR American Federation for Medical Research, formerly the American Federation for Clinical Research (AFCR)
AHA American Heart Association
AHCPR Agency for Health Care Policy Research (NIH)
AICRC Association of Independent Clinical Research Contractors (UK)
AIDS acquired immune deficiency syndrome, acquired immunodeficiency syndrome
ALCOA attributable, legible, contemporaneous, original, accurate (dimensions of data integrity)
am ante meridian, morning (12:00 midnight thru 11:59:59)
AMA American Medical Association
AMC antibody-mediated cytotoxicity
AmFAR American Foundation for AIDS Research
AMG Arzneimittelgesetz (German Drug Law)
AMWA American Medical Writers Association
ANDA Abbreviated New Drug Application (for a generic drug)
ANOVA analysis of variance (statistics)
ANSI American National Standards Institute
AOAC Association of Official Analytical Chemists
APB Association Pharmaceutique Belge (Belgium)
APhA American Pharmacists Association
API active pharmaceutical ingredient
APPI Academy of Pharmaceutical Physicians and Investigators
ARCS Association of Regulatory & Clinical Scientists (Australia)
ARENA Applied Research Ethics National Association (discontinued name, see PRIM&R)
ARO academic research organization
ASAP administrative systems automation project (FDA)
ASCII American Standard Code for Information Interchange (computer files)
ASCPT American Society for Clinical Pharmacology and Therapeutics
ASP application service provider delivering a computer application via the WWW
ASQ American Society for Quality, formerly American Society for Quality Control
ATC Anatomic-Therapeutic-Chemical Coding dictionary
AUC area under the curve (statistics)
BARQA British Association of Research Quality Assurance
BCE beneficial clinical event
BDPA Bureau of Drug Policy and Administration (China)
BEUC European Bureau of Consumer Unions
BfArM Bundesinstitut für Arzneimittel und Medizinprodukte (Federal Institute for Drugs and Medical Devices, Germany)
BGA Bundesgesundheitsamt (Federal health office; former German public health agency)
BGVV Bundesinstitut für gesundheitlichen Verbraucherschutz und Veterinärmedizin (Federal Institute for Health Protection of Consumers and Veterinary Medicine, Germany)
BIO Biotechnology Industry Organization
BIRA British Institute of Regulatory Affairs
BLA Biologics License Application (FDA)
BPI Bundesverband der Pharmazeutischen Industrie EV (Germany)
BrAPP British Association of Pharmaceutical Physicians
BRIDG Biomedical Research Integrated Domain Group
BSA body surface area
CA Competent Authority (regulatory body charged with monitoring compliance with European Union member state national statutes and regulations)
caBIG cancer Biomedical Informatics Grid
CAPRA Canadian Association of Professional Pharmaceutical Regulatory Affairs (also ACPR Association canadienne des professionnels en réglementation)
CAS Chemical Abstracts Service
CBER Center for Biologics Evaluation and Research (FDA)
CCI Committee on Clinical Investigations. See also Ethics Committee box in the Glossary.
CCPPRB Comité Consultative pour la Protection des Personnes dans les Recherches Biomédicales (France). See also Ethics Committee box in the Glossary.
CCRA Certified Clinical Research Associate. Certification issued to monitors by ACRP.
CCRC Certified Clinical Research Coordinator. Certification issued to clinical coordinators by ACRP.
CCRP Certified Clinical Research Professional. SoCRA certification of coordinators, monitors, and other research professionals
CDA Clinical Document Architecture
CDASH Clinical Data Acquisition Standards Harmonization (a 2006 CDISC initiative)
CDC Centers for Disease Control and Prevention
CDE common data element
CDER Center for Drug Evaluation and Research (FDA)
CDISC Clinical Data Interchange Standards Consortium
CDM clinical data management
CDRH Center for Devices and Radiological Health (FDA)
CEN Comité Européen de Normalisation (European Committee for Standardization)
CEU Continuing Education Unit
CF consent form
CFR Code of Federal Regulations (usually cited by title and part; for example, Title 21, Part 211 is shown as 21 CFR 211)
cGMP current good manufacturing practices
CHI Consolidated Health Initiative (eGov)
CHR Committee on Human Research. See also Ethics Committee box in the Glossary.
CIOMS Council for International Organisations of Medical Sciences (postapproval international ADR reporting, UK)
CIP Certified IRB Professional
CIS Commonwealth of Independent States
CLIA Clinical Laboratory Improvement Amendments
Cmax concentration maximum; used in pharmacokinetics and bioequivalence to indicate maximum plasma concentration for a drug
CMC chemistry, manufacturing, and control
CME Continuing Medical Education
CMS Centers for Medicare & Medicaid Services
CNS central nervous system
CONSORT Consolidated Standards of Reporting Trials
COP CDISC Operating Process/Procedure
COSTART Coding Symbols for a Thesaurus of Adverse Reaction Terms. See also MedDRA.
CPHS Committee for the Protection of Human Subjects
CPMP Committee for Proprietary Medicinal Products (EU)
CPSC Consumer Product Safety Commission (U.S.)
CRA clinical research associate. See also CCRA.
CRADA Cooperative Research And Development Agreement (with US Government entities such as FDA or NIH)
CRB case record book
CRB Central Review Board
CRC clinical research coordinator. See also CCRC, SC, SSC.
CRF case report form (sometimes case record form)
CRIX Clinical Research Information Exchange
CRO contract research organization. See also IPRO.
CSDD Center for the Study of Drug Development (Tufts)
CSF Collaborative Standards Forum (CDISC)
CSF cerebrospinal fluid
CSF colony stimulating factor
CSM Committee on Safety of Medicines (UK)
CSO Consumer Safety Officer (FDA)
CSR clinical study report
CSU clinical supply unit
CT clinical trial
CTA Clinical Trial Agreement
CTC Clinical Trial Certificate (UK)
CTD Common Technical Document
CTEP Cancer Therapy Evaluation Program
CTM clinical trials materials
CTX Clinical Trial Exemption (MCA)
CV curriculum vitae
CVM Center for Veterinary Medicine (FDA)
DAWN Drug Abuse Warning Network
DD Department of Drugs (Swedish regulatory agency)
DDI drug–drug interaction
DEA Drug Enforcement Administration (U.S.)
DEN Drug Experience Network
DES Data Encryption Standard
DESI Drug Efficacy Study Implementation notice (FDA, to evaluate drugs in use before 1962)
DGPharMed Deutsche Gesellschaft für Pharmazeutische Medizin (German Society of Pharmaceutical Medicine), formerly FäPI
DHEW Department of Health, Education and Welfare (U.S., now split into DHHS and Department of Education)
DHHS Department of Health and Human Services (U.S.)
DHTML Dynamic HTML (IT)
DIA Drug Information Association
DICOM Digital Imaging and Communications in Medicine
DLT dose-limiting toxicity
DMB Data Management Biomedical (France)
DPC-PTR Act Drug Price Competition and Patent Term Restoration Act of 1984 (also Waxman-Hatch or Hatch-Waxman bill)
DSI Division of Scientific Investigations (FDA)
DSM Diagnostic and Statistical Manual (of the American Psychiatric Association)
DSMB data safety monitoring board
DSNP Development of Standardized Nomenclature Project (FDA)
DST daylight saving time
DTC direct-to-consumer (drug advertising)
DTD Document Type Definition (XML)
E3C European CDISC Coordinating Committee
EAB Editorial Advisory Board (Applied Clinical Trials)
EAB Ethical Advisory Board. See also Ethics Committee in the Glossary.
EC ethics committee. See also Ethics Committee in the Glossary.
EC European Commission (in documents older than the mid-1980s, EC may mean European Community)
ECG electrocardiogram
ECG European CDISC Group
ECJ European Court of Justice
ECOG Eastern Cooperative Oncology Group (U.S.)
ECPHIN European Community Pharmaceutical Information Network
eCRF electronic case report form
eCTD electronic Common Technical Document
EDC electronic data capture/collection
EDI electronic data interchange
EDR electronic document room. NOTE: The EDR is an extension of the e-Submissions central document room. A check is performed on each submission sent to the EDR for file formats used and the integrity of bookmarks and hypertext links.
EEC European Economic Community, now EU; some regulatory documents still have EEC document numbers.
EFGCP European Forum for Good Clinical Practice
EFPIA European Federation of Pharmaceutical Industries and Associations
EFTA European Free Trade Association
eHR electronic health record
EIR Establishment Inspection Report (FDA)
ELA Establishment License Application (FDA)
EMEA European Medicines Agency
EMWA European Medical Writers Association
EORTC European Organisation for Research and Treatment of Cancer
EP European Parliament
EPAR European Public Assessment Report
EPO European Patent Office; erythropoietin
EPRG European Pharmacovigilance Research Group
ER Essential Requirements (EMEA)
ERSR electronic regulatory submissions and review (FDA's e-Submissions processing group)
eRX electronic prescribing
ESRA European Society of Regulatory Affairs
ESTRI Electronic Standards for the Transfer of Regulatory Information (ICH)
EU European Union
EUDRA European Union Drug Regulatory Authorities
EUDRACT European Union clinical trials database
EWG expert working group
FAQ frequently asked questions
Farmindustria The Association of Italian Pharmaceutical Manufacturers
FD&C Act Food, Drug, and Cosmetic Act (U.S.)
FDA Food and Drug Administration (U.S.)
FDAMA FDA Modernization Act
FDLI Food and Drug Law Institute
FFPM Fellow of the Faculty of Pharmaceutical Medicine (UK)
FIPS Federal Information Processing Standards
FRCP Fellow of the Royal College of Physicians, sometimes followed by a place name—for example, FRCP (Edin.)—that indicates a university medical school
FTC Federal Trade Commission (U.S.)
FTP File Transfer Protocol
FWA Federalwide Assurance
GAO Government Accountability Office (U.S. government)
GBP good business practice
Gbps gigabits, or billions of bits per second (data transmission)
GCP good clinical practice
GCRP good clinical research practice
GLP good laboratory practice
GMP good manufacturing practices
GMT Greenwich mean time. See UTC.
GP general practitioner; general practice (UK)
GPMS good postmarketing surveillance practice (Japan)
GRAS generally regarded as safe (foods)
GRP good review practice (CDER)
GXP good [pharmaceutical] practice
HA health authority (UK)
HCFA Health Care Financing Administration; now renamed The Centers for Medicare & Medicaid Services (CMS).
HEX Human Experimentation Committee. See also Ethics Committee box in the Glossary.
HHS Department of Health and Human Services (U.S., also called DHHS)
HIMA Health Industry Manufacturers Association
HIMSS Healthcare Information and Management Systems Society
HIPAA Health Insurance Portability and Accountability Act
HIT Healthcare Information Technology
HL7 Health Level 7 (a not-for-profit ANSI-accredited standards developing/development organization (SDO))
HPB Health Protection Branch, Laboratory Centre for Disease Control (Canada); has been superseded by Health Canada
HPLC high performance liquid chromatography
HSRC Human Subjects Review Committee. See also Ethics Committee box in the Glossary.
HTML Hypertext Markup Language
HTTP Hypertext Transfer Protocol
I3C India CDISC Coordinating Committee
IAB Industry Advisory Board (for CDISC)
IB investigator's brochure
IC informed consent
ICD9 International Classification of Diseases, 9th revision. See also MedDRA.
ICF informed consent form
ICG India CDISC Group
ICH International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
ICR Institute of Clinical Research (formerly ACRPI, Association for Clinical Research in the Pharmaceutical Industry, UK)
ICSR individual case safety report
ICTH International Committee on Thrombosis and Haemostasis
ICTRP International Clinical Trials Registry Platform (WHO)
IEC independent ethics committee. See also Ethics Committee box in the Glossary.
IEEE Institute of Electrical and Electronic Engineers, Inc.
IFAPP International Federation of Associations of Pharmaceutical Physicians
IFPMA International Federation of Pharmaceutical Manufacturers and
Associations
IG Inspector General (HHS)
IHI Institute for Healthcare Improvement
IKS Interkantonale Kontrollstelle für Heilmittel (Switzerland)
IMP investigational medicinal product; investigational materials plan
IMPD Investigational Medicinal Product Dossier (EUDRA)
IND Investigational New Drug application (FDA). See also TIND.
INN International Nonproprietary Name
IOM Institute of Medicine (National Academy of Science, U.S.)
IPRO independent pharmaceutical research organization. See also CRO.
IRB institutional review board; independent review board. See also Ethics Committee box in the Glossary.
IRD international registration document
IS International System of Units (may also be referred to as SI – Systéme Internationale)
ISCB International Society for Clinical Biostatistics
ISDN Integrated Services Digital Network
ISO International Organization for Standardization
ISOQOL International Society for Quality of Life Research
ISP Internet service provider
IT information technology
ITU-T International Telecommunication Union – Telecommunication Standardization Sector
IUPAC International Union of Pure and Applied Chemistry
IVD in vitro diagnostics
IVRS interactive voice response system
J3C Japan CDISC Coordinating Committee
JCAHO Joint Commission on Accreditation of Healthcare Organizations
JCG Japan CDISC Group
JMA Japan Medical Association
JPMA Japan Pharmaceutical Manufacturers Association
Kbps kilobits, or thousands of bits per second (data transmission)
LAB Laboratory Data Model (CDISC)
LAN local area network
LIF Swedish Pharmaceutical Industry Association
LKP Leiter der Klinischen Prüfung
LOA letter of agreement
LOINC logical observations, identifiers, names, and codes
LREC local research ethics committee (UK). See also Ethics Committee box in the Glossary.
MA marketing authorization
MAA Marketing Authorisation Application (EU)
MAH Marketing Authorization Holder (EU)
MaPP Manual of Policies and Procedures (CDER)
Mbps megabits, millions of bits per second (data transmission)
MCA Medicines Control Agency (UK), now merged with Medical Devices Agency into MHRA.
MDR medical device
reporting
MedDRA Medical Dictionary for Regulatory Activities (new global standard medical terminology designed to supersede other terminologies used in the medical product development process, including COSTART, ICD9, and others)
MedID Medicinal Product Identifier
MEDLARS Medical Literature Analysis and Retrieval System
MEFA Association of the Danish Pharmaceutical Industry
MEP Member of the European Parliament
MHLW Ministry of Health, Labor and Welfare (Japan)
MHRA Medicines and Healthcare products Regulatory Agency
MIAME minimum information about a microarray experiment (standard for microarray data)
MOH Ministry of Health (UK, Canada, others)
MOPH Ministry of Public Health (Thailand, Yemen, others)
MOU memorandum of understanding (an MOU between FDA and a regulatory agency in another country allows mutual recognition of inspections)
MPR Medical Products Agency (Swedish Regulatory Agency)
MR Medical Representative (Japan)
MRA medical research associate
MREC Multicentre Research Ethics Committee (UK). See also Ethics Committee in the Glossary.
MRI magnetic resonance imaging
MTD maximum tolerated dose
MVP master validation plan
NABR National Association for Biomedical Research
NAF Notice of Adverse Findings (FDA post-audit letter)
NAI No Action Indicated (most favorable FDA post-inspection classification)
NAS new active substance (UK)
NAS-NRC National Academy of Sciences-National Research Council (U.S.)
NBAC National Bioethics Advisory Commission (U.S.)
NCCAM National Center for Complementary and Alternative Medicine, formerly Office of Alternative Medicine (NIH)
NCCTG North Central Cancer Treatment Group (U.S.)
NCDM Nordic Clinical Data Management (Association)
NCE new chemical entity
NCHGR National Center for Human Genome Research (NIH)
NCHS National Center for Health Statistics (in CDC)
NCI National Cancer Institute (NIH)
NCPDP National Council for Prescription Drug Programs
NCPIE National Council on Patient Information and Education (Washington DC)
NCR no carbon [paper] required
NCRR National Center for Research Resources (NIH)
NCVIA National Childhood Vaccine Injury Act (1986)
NDA New Drug Application (FDA)
NDS New Drug Submission (Canada's new drug application)
NEFARMA Dutch Association of the Innovative Pharmaceutical Industry
NEI National Eye Institute (NIH)
NGO nongovernmental organization
NHI National Health Insurance (Japan)
NHIH National Healthcare Information Network
NHLBI National Heart, Lung, and Blood Institute (NIH)
NHS National Health Service (UK)
NIA National Institute on Aging (NIH)
NIAAA National Institute on Alcohol Abuse and Alcoholism (NIH)
NIAID National Institute of Allergies and Infectious Diseases (NIH)
NIAMS National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH)
NIBIB National Institute of Biomedical Imaging and Bioengineering
NICHD National Institute of Child Health and Human Development (NIH)
NIDA National Institute on Drug Abuse (NIH)
NIDCD National Institute on Deafness and Other Communication Disorders (NIH)
NIDCR National Institute of Dental and Craniofacial Research (NIH)
NIDDK National Institute of Diabetes and Digestive and Kidney Diseases (NIH)
NIEHS National Institute of Environmental Health Sciences (NIH)
NIGMS National Institute of General Medical Sciences (NIH)
NIH National Institutes of Health (DHHS)
NIMH National Institute of Mental Health (NIH)
NINDS National Institute of Neurological Disorders & Stroke (NIH)
NINR National Institute of Nursing Research (NIH)
NIRB See NRB. See also Ethics Committee, Independent IRB in the Glossary.
NLM National Library of Medicine (NIH)
NME new molecular entity
NOAEL no-observed-adverse-effect level (IUPAC)
NOEL no observable effect level (dose of an experimental drug given preclinically that does not produce an observable toxicity)
NRB noninstitutional review board, also known as an independent review board. See also Ethics Committee in the Glossary, NIRB.
NSCLC non-small cell lung carcinoma
NTP National Toxicology Program
OAI Official Action Indicated (serious FDA post-inspection classification)
OAM See NCCAM.
ODAC Oncologic Drugs Advisory Committee (U.S.)
ODE Office of Drug Evaluation
ODM Operational Data Model [CDISC]
OGD Office of Generic Drugs (CDER, formerly DGB)
OGE Office of Government Ethics
OHITA Office of Health Information Technology Adoption (ONCHIT)
OHRP Office for Human Research Protections
OIG Office of the Inspector General
OIS Office of Interoperability and Standards
OJC Official Journal of the European Union-C Series (Information)
OJEC Official Journal of the European Communities
OJL Official Journal of the European Union-L Series (Legislation)
OMB Office of Management and Budget (U.S.)
ONCHIT Office of the National Coordinator for Health Information Technology
OPR Office of Policy and Research
OPRR Office for Protection from Research Risks (predecessor to OHRP)
OSHA Occupational Safety & Health Administration (U.S.)
OTA Office of Technology Assessment (U.S., abolished 1995)
OTC over-the-counter (refers to nonprescription drugs)
PAB Pharmaceutical Affairs Bureau (Japan)
PAHO Pan American Health Organization
PCC Poison Control Center
PCP pneumocystis carinii pneumonia
PD pharmacodynamics
PDA personal digital assistant (Palm Pilot® , for example)
PDF Portable Document Format
PDQ Physicians' Data Query (NCI-sponsored cancer trial registry)
PDR Physicians' Desk Reference
PDUFA Prescription Drug User Fee Act (1992, U.S.)
PEM prescription event monitoring
PERI Pharmaceutical Education & Research Institute (not-for-profit division of PhRMA)
PFT pulmonary function test
PhPID pharmaceutical product identifier
PhRMA Pharmaceutical Research and Manufacturers of America (formerly PMA)
PHS Public Health Service (U.S.)
PI principal investigator
PK pharmacokinetics
PKI public key infrastructure
PLA Product License Application (FDA)
pm (post meridian, evening (12 noon thru 23:59:59)
PMA Pre-Market Approval application (FDA)
PMS postmarketing surveillance
PPI Patient Package Insert
PPO preferred provider organization; policy and procedure order
PR partial response; pulse rate
PRIM&R Public Responsibility in Medicine and Research (Boston, MA)
PROG Peer-Review Oversight Group (NIH)
PROMIS Patient Reported Outcomes Measurement Information System
PSUR periodic safety update report
PTC points to consider
QA quality assurance
QAU quality assurance unit
QC quality control
QL quality of life
QOL quality of life (also QoL)
R&D research and development
RADAR risk assessment of drugs–analysis and response
RAPS Regulatory Affairs Professionals Society
RCRIM Regulated Clinical Research and Information Management (HL7)
RCT randomized clinical trial
RDE remote data entry
RDRC Radioactive Drug Research Committee (FDA)
REB research ethics board (Canada)
RFP request for proposal
RHIO regional health information organization
RIM Reference Information Model (HL7)
RKI Robert-Koch-Institut, Bundesinstitut für Infektionskrankheiten und nich-übertragbare Krankheiten (Federal Institute for Infectious and Non-communicable Diseases, Germany)
RL Regulatory Letter (FDA – post-audit letter)
SAE serious adverse event
SAS Statistical Analysis System (commonly used statistical analysis package)
SATCM State Administration of Traditional Chinese Medicine (China)
SBA Summary Basis of Approval
SC study coordinator. See also CRC, CCRC, SSC.
SCDM Society for Clinical Data Management (U.S.)
SCT Society for Clinical Trials
SD standard deviation (statistics)
SDA State Drug Administration (China)
SDM Submission Data Model (CDISC)
SDO standards development organization
SDS Submission Data Standards (CDISC)
SDTM Subject Data Tabulation Model (CDISC)
SDV source document (data) verification
SE standard error (statistics)
SEA Single European Act of 1987
SEER Surveillance, Epidemiology, and End Results program (National Cancer Institute)
SGML Standard Generalized Markup Language
SIAC Special Interest Area Community (DIA)
SIG Special Interest Group (HL7)
SLA service level agreement
SMART Submission Management and Review Tracking (FDA)
SME significant medical event
SMO site management organization
SmPC summary of product characteristics. See also SPC.
SNDA Supplemental New Drug Application
SNIP Syndicat National de l'Industrie Pharmaceutique (France)
SNOMED Systematized Nomenclature of Medicine (a dictionary)
SoCRA Society of Clinical Research Associates
SOP standard operating procedure
SPAC State Pharmaceutical Administration of China
SPC summary of product characteristics. See also SmPC.
SPL Structured Product Labeling (HL7, FDA)
SPM Society of Pharmaceutical Medicine (UK)
SQA Society of Quality Assurance
SQAP systems quality assurance plan
SSC study site coordinator. See also CRC, CCRC, SC.
SSCT Swedish Society for Clinical Trials
SSFA Società di Scienze Farmacologiche Applicate (Italy)
STF study tagging file
STT short term test
SUAE serious unexpected adverse event
SUD sudden unexpected death
SWOG Southwest Oncology Group (U.S.)
TC Technical Committee (HL7)
TCC Technical Coordinating Committee (CDISC)
TCP/IP Transmission Control Protocol/Internet Protocol
TermID Controlled Vocabulary Term Identifier
TESS treatment-emergent signs and symptoms
TIND treatment IND. See also IND.
TK toxicokinetics
Tmax the time after dosing when Cmax occurs
TMO trial management organization
UMT universal mean time (also known as Greenwich mean time). See UTC.
URL uniform resource locator (address of a Web site)
USAN United States Adopted Name
USC United States Code (book of laws)
USDA U.S. Department of Agriculture
USP United States Pharmacopeia
UST user site testing. Synonym for UAT (user acceptance testing)
UT universal time (also known as Greenwich mean time). See UTC.
UTC coordinated universal time (international standard since 1972)
VA Veterans Administration (officially, U.S. Department of Veterans Affairs)
VAERS Vaccine Adverse Event Reporting System
VAI Voluntary Action Indicated (FDA postaudit inspection classification)
VCDE vocabularies and common data elements (caBIG)
VGDS voluntary genomic data submission
VPN virtual private network
WAN wide area network
WHO World Health Organization
WHOART World Health Organization Adverse Reaction Terminology
WL Warning Letter (most serious FDA post-audit letter, demands immediate action within 15 days)
WR written request
WRAIR Walter Reed Army Institute of Research (DoD)
WTO World Trade Organization
www World Wide Web
XML eXtensible Markup Language
FDA Fast Tracks Johnson & Johnson’s Nipocalimab for Fetal Neonatal Alloimmune Thrombocytopenia
March 27th 2024Johnson & Johnson is moving forward with a pair of Phase III trials of nipocalimab to reduce the risk of fetal neonatal alloimmune thrombocytopenia in alloimmunized pregnant patients.
Citius Pharmaceuticals Resubmits BLA to FDA for Lymphir to Treat Cutaneous T-Cell Lymphoma
March 19th 2024Pivotal Phase III Study 302 trial data show an objective response rate of 36.2% based on an independent review committee assessment in the treatment of relapsed/refractory cutaneous T-cell lymphoma.